9d
Hosted on MSNMerit Medical Celebrates FDA Approval of WRAPSODYâ„¢An update from Merit Medical Systems ( ($MMSI) ) is now available. On January 28, 2025, Merit Medical Systems held a conference call to discuss ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease.
The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
Medical devices are ... year of the Food and Drug Administration’s (FDA) new guidance on security and privacy play out, putting pressure on manufacturers in both the premarket and postmarket.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results